or Try an Advanced Search...

    Advanced Prostate Cancer Stocks List

    Symbol Grade Name % Change
    EPIX F ESSA Pharma Inc. 3.98
    ABBV D AbbVie Inc. 3.04
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Pharmaceutical Adalimumab Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Cancer Chronic Idiopathic Constipation Combination Drugs Constipation Crohn's Disease Depressive Disorder Endometriosis Eye Care Products Genotype Hematological Malignancies Hepatitis C Hepatitis C Virus Histopathology Hypothyroidism

    Related ETFs - A few ETFs which own one or more of the above listed Advanced Prostate Cancer stocks.

    Symbol Grade Name Weight
    HDLB B ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    BOTZ B Global X Robotics & Artificial Intelligence Thematic ETF 9.31
    MEDX F Horizon Kinetics Medical ETF 7.81
    GRID C First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund 7.75
    FDL A First Trust Morningstar ETF 6.79
    View all Advanced Prostate Cancer ETFs...
    Compare ETFs
    Compare BOTZ to MEDX Compare GRID to FDL Compare HDLB to GRID

        Advanced Prostate Cancer Stocks Recent News

        Date Stock Title
        Nov 22 ABBV AbbVie gains on Leerink Partners upgrade to Outperform
        Nov 22 ABBV AbbVie: Upgrading To 'Strong Buy' After Pullback
        Nov 22 ABBV J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
        Nov 22 ABBV AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
        Nov 22 ABBV AbbVie upgraded to outperform by Leerink on recent sell-off
        Nov 20 ABBV Unpacking the Latest Options Trading Trends in AbbVie
        Nov 19 ABBV ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
        Nov 19 ABBV Where Will AbbVie Be in 5 Years?
        Nov 19 ABBV RVPH: Year-End OLE Update
        Nov 19 ABBV What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
        Nov 18 ABBV AbbVie snaps eight straight sessions of losses
        Nov 18 ABBV Aldeyra announces FDA acceptance of resubmitted reproxalap application
        Nov 18 ABBV AbbVie's Ovarian Cancer Drug Elahere Gets Approval in Europe
        Nov 18 ABBV Allergan Aesthetics Offers Free Business Education Courses Online to Support Growing Practices with Allergan Aesthetics Products
        Nov 18 ABBV AbbVie’s Elahere wins European approval for certain ovarian cancers
        Nov 18 ABBV Why This Beaten-Down Dividend Stock Is a No-Brainer Buy on the Dip
        Nov 18 ABBV AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer
        Nov 17 ABBV Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
        Nov 17 ABBV AbbVie's (NYSE:ABBV) Shareholders Will Receive A Bigger Dividend Than Last Year
        Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Pharmaceutical Adalimumab Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Cancer Chronic Idiopathic Constipation Combination Drugs Constipation Crohn's Disease Depressive Disorder Endometriosis Eye Care Products Genotype Hematological Malignancies Hepatitis C Hepatitis C Virus Histopathology Hypothyroidism
        Advanced Prostate Cancer

        Advanced prostate cancer is a form of prostate cancer that has spread beyond the prostate gland to other parts of the body, such as the bones, lymph nodes, or other organs. It is also known as metastatic prostate cancer. Advanced prostate cancer is typically more difficult to treat than early-stage prostate cancer, and the prognosis is generally poorer. Treatment options may include hormone therapy, chemotherapy, radiation therapy, and/or surgery.

        Browse All Tags